Farms.com Home   News

Acute levels of hunger around the world are breaking records again this year, according to the Canadian Foodgrains Bank

Last week Thursday at the Buhler Active Living Centre, a Canadian Foodgrains Bank presentation by Program Manager Stefan Epp-Koop took place regarding the work of the organization, networking through 15 different church-based agencies, to end hunger around the world.

Epp-Koop explained the rising number of people experiencing acute hunger around the world is growing.

"Now there are 193 million people who are acutely food insecure, who are going hungry in our world today. That number is unprecedented. It's a record number. Last year, there was only 150 million. That was also a record, but it's up 40 million since then, and we expect it to continue to grow next year. We are in a hunger crisis, that 193 million people represents a crisis around the world, in terms of levels of hunger and food insecurity."

While the stories shared in the presentation were about locations in Africa, Epp-Koop noted, there is a global need.

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.